Navigation Links
Medicis in Medical News

BioMarin Announces Second Quarter 2009 Financial Results

... June 30, 2009, BioMarin had cash and short and long-term investments totaling $485.3 million. During the quarter, BioMarin made the final payment to medicis of $70.6 million related to the Orapred transaction. "During the quarter, we reported encouraging results from the Phase I PEG-PAL study, initi...

Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation

... to use it. Dr. John L. LeRoy is helping Atlanta-area patients reduce the appearance of fine lines and wrinkles with the new Dysport®, licensed by medicis from French developer Ipsen. Dysport® functions much the same way as BOTOX® injections, and may now be considered one of its main competitors....

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

New Survey Reveals High Expectations for Popular Aesthetic Injections

...linum Toxin Survey NewsWorthy Analysis. February--March 2009. Data on file, medicis Pharmaceutical Corporation. 2. Kelton Research. Botulinum Toxin Survey Topline Report. February--March 2009. Data on file, medicis Pharmaceutical Corporation. Important Safety Information Dysport...

Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort

...d effective, Hydrelle is also a financially attractive alternative to traditional fillers such as Juvederm(R) by Allergan Medical, and Restylane(R) by medicis Pharmaceutical. Hydrelle has been specifically formulated to deliver rapid results comparable to other hyaluronic acid fillers; and the lidocaine...

Hyperion Therapeutics Raises $60 Million Series C

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Joseph E. Whitters Joins MyoScience, Inc. Board of Directors

...ns in aesthetics. Major investors in MyoScience, include De Novo Ventures, Accuitive Medical Ventures, Nexus Medical Partners, Saratoga Ventures, and medicis Capital GmbH. Press Contacts: Robert M. Curtis, President and CEO MyoScience, Inc. bcurtis@myoscience.com (650) 474-2600...

Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble

...omote the Dysport(TM) brand as part of a U.S. sales agreement with the manufacturer, Ipsen. Adding Dysport(TM) to their dermal filler empire positions medicis as a formidable foe to Allergan and their arsenal of beauty treatments (Botox(R) and the Juvederm(R) hyaluronic acid gel fillers). Botox(R) by Al...
Medicis in Medical Technology

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

...al unmet needs and underserved patient populations in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders

...enal excretion of phenylacetylglutamine, which is formed from phenylacetic acid and glutamine. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conducti...

RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial

... RADIESSE(R) is a registered trademark of BioForm Medical, Inc. Restylane(R) is a registered trademark of HA North American Sales AB, a subsidiary of medicis Pharmaceutical Corporation. Contact: Adam Gridley 650.286.4025 Vice President, Corporate Development BioForm Medical, Inc. ...
Medicis in Biological Technology

DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania

...e soft-tissue volume loss, thus returning the dermis to its original youthful state. Current marketed fillers include market-leader Restylane, sold by medicis Pharmaceutical, and Radiesse sold by Bioform. "We were very pleased to be selected for an investment by Ben Franklin Technology Partners as a part o...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...SI ) Imclone Systems (Nasdaq: IMCL ) Inverness Medical Innovations (Amex: IMA ) Invitrogen Corp. (Nasdaq: IVGN ) Medarex Inc. (Nasdaq: MEDX ) medicis Pharmaceutical (NYSE: MRX ) Mentor Corp. (NYSE: MNT ) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX ) PDL BioPharma, Inc. (Nasdaq: PDLI ) Pharmion C...

BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results

...demarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...

Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event

...s commitments and capitalize on the opportunity presented by our recently announced strategic collaboration with Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation," said Chris Rivera, President and CEO. "This team brings a unique and proven track record of developing, gaining regulator...

Hyperion Therapeutics Secures $40 Million In Series B Round

...confidence in Hyperion and our team," said Chris Rivera, President and CEO of Hyperion. "The funding will allow us to complete the licensing deal with medicis Pharmaceutical Corporation (see press release dated August 28, 2007), build out our management team, advance our clinical trials in UCD and HE, and be...

BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco

... trademarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...
Other Tags
(Date:4/17/2014)... have identified the first genetic variant specifically associated ... accounting for around 10-15 per cent of all ... of the breast cancer sub-type, called invasive lobular ... causes of this particular kind of breast cancer, ... research, published today (Thursday) in the journal ...
(Date:4/17/2014)... to a study published today in PLOS Pathogens ... where malaria is common can mount an immune response ... to avoid repeated bouts of high fever and illness ... their bloodstream. The findings may help researchers develop future ... the malaria parasite. , Each year, approximately 200 million ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... that as many as 10 million older Americans suffer ... and isolation. , However, new research a project ... Americans for six years found that Internet use ... by more than 30 percent. , "That,s a very ... professor of telecommunication, information studies and media who led ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2
(Date:4/20/2014)... doctors have long known that people with Down syndrome ... (ALL) during childhood, they haven,t been able to explain ... investigators has uncovered a connection between the two conditions. ... journal Nature Genetics , the researchers track the ... in Down syndrome to the cellular havoc that occurs ...
(Date:4/18/2014)... world population predicted to reach 9 billion by ... that considers human-altered landscapes such as farmland, according ... habitat that supports it might be an increasingly ... three-quarters of the land surface is directly affected ... human-caused impacts such as climate change. But what ...
(Date:4/18/2014)... Asteroid and comet impacts can cause widespread ecological ... even global scales. But new research from Brown University ... ancient life at the time of an impact. , ... has found fragments of leaves and preserved organic compounds ... in Argentina. The material could provide a snapshot of ...
Breaking Biology News(10 mins):Dana-Farber researchers uncover link between Down syndrome and leukemia 2Dana-Farber researchers uncover link between Down syndrome and leukemia 3Stanford researchers rethink 'natural' habitat for wildlife 2Stanford researchers rethink 'natural' habitat for wildlife 3Stanford researchers rethink 'natural' habitat for wildlife 4Impact glass stores biodata for millions of years 2Impact glass stores biodata for millions of years 3
Other Contents